Flagship Ventures creates and finances companies in therapeutics, medical technologies and sustainability.


12.23.2014	Selecta and Skolkovo Foundation Collaboration to Develop a Synthetic Vaccine Particle in the field of Immuno-oncology
12.18.2014	Pronutria Biosciences Announces Issuance of Key Patents from USPTO on Compositions and Methods Relating to Oral Biologics
12.16.2014	Quanterix Announces the Simoa Accelerator, an Innovation Center for Biomarker Research and Custom Assay Development
12.16.2014	Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
12.12.2014	Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors
12.11.2014	Syros Pharmaceuticals Announces New Research Published on CDK7 in Lung and Pediatric Cancers